Appendix Table B. Medication Codes to Identify Immunocompromising Conditions for Assessment

Appendix Table B. Medication Codes to Identify Immunocompromising Conditions for Assessment

Appendix Table B. Medication Codes to Identify Immunocompromising Conditions for Assessment of Risk

Condition (Code Type)
Code(s) or Drug Category / Description
HIV (NDCs, HCPCS)
Abacavir sulfate
Abacavir sulfate/lamivudine
Abacavir sulfate/lamivudine
Amprenavir/vitamin E
Atazanavir sulfate
Darunavirethanolate
Delavirdinemesylate
Didan/calcium carb/magnesium
Didan/mag salt/al nacb/sod cit
S0137 / Didanosine
Efavirenz
Efavirenz/emtricitab/tenofovir
Emtricitabine
Emtricitabine/tenofovir
J1324 / Enfuvirtide
Etravirine
Fosamprenavir calcium
Indinavir sulfate
Lamivudine
Lamivudine/zidovudine
Lopinavir/ritonavir
Maraviroc
Nelfinavirmesylate
Nevirapine
Raltegravir potassium
Ritonavir
Ritonavir/lopinavir
S0140 / Saquinavir
Stavudine
Tenofovirdisoproxilfumarate
Tipranavir
Zalcitabine
J3485 / Zidovudine
Zidovudine/lamivudine
Malignant neoplasms (NDC, HCPCS)
Alkylating agents / Bendamustine, Busulfan, Carmustine, Carmustine/polifeprosan, Chlorambucil, Cyclophosphamide, Dacarbazine, Estramustine, Ifosfamide, Lomustine, Mechlorethamine, Melphalan, Procarbazine, Streptozocin, Temozolomide, Thiotepa, Uracil mustard
Platinum agents / Carboplatin, Cisplatin, Oxaliplatin
Antimetabolites / Antifolate: Methotrexate, Pemetrexed
Purine antagonist: Cladribine, Clofarabine, Cytarabine, Fludarabine, Mercaptopurine, Nelarabine, Pentostatin, Thioguanine
Pyrimidine:Azacitidine
Pyrimidine Antagonist:Capecitabine, Floxuridine, Fluorouracil, Gemcitabine
Miscellaneous:Hydroxyurea
Antimicrotubule agents / Taxanes: Docetaxel, Paclitaxel, Albumin-bound paclitaxel
Vinca alkaloids: Vinblastine, Vincristine, Vinorelbine
Epothilone analog: Ixabepilone
Topoisomerase-active agents / Topoisomerase I inhibitors:Irinotecan, Topotecan
Topoisomerase II inhibitors:Daunorubicin, Doxorubicin, Pegylated liposomal doxorubicin, Epirubicin, Idarubicin, Mitoxantrone, Valrubicin, Etoposide
Podophyllotoxins / Teniposide
Antineoplastic antibiotic / Bleomycin, Dactinomycin, Mitomycin C, Plicamycin
Endocrine agents / Androgen:Testolactone, Fluoxymesterone
Antiandrogens:Bicalutamide, Flutamide, Nilutamide
Aromatase inhibitors:Aminoglutethimide, Anastrozole, Exemestane, Letrozole
Estrogen receptor antagonists:Raloxifene, Tamoxifen, Toremifene, Fulvestrant
GnRH agonists:Histrelin, Triptorelin
LNRH agonists:Goserelin, Leuprolide
LNRH antagonist:Abarelix
Progestins:Medroxyprogesterone, Megestrol
Estrogens: Diethylstilbestrol (DES), Ethinyl estradiol
Biologically-directed therapies / Molecular targets:Alitretinoin, Bexarotene, Bortezomib, Dasatinib, Erlotinib, Gefitinib, Imatinib, Lapatinib, Nilotinib, Sorafenib, Sunitinib, Temsirolimus, Tretinoin
Monoclonal antibodies:Alemtuzumab, Bevacizumab, Cetuximab, Gemtuzumab, Ibritumomab, Panitumumab, Rituximab, Tositumomab, Trastuzumab
Immune therapies / Aldesleukin (IL-2), Interferon alfa-2a, Interferon alfa-2b, Lenalidomide, Thalidomide
Misc agents / Altretamine, Arsenic trioxide, Asparaginase, BCG vaccine, Decitabine, Denileukin, Levamisole, Mitotane, Pegaspargase, Porfimer, Strontium-89, Zoledronic acid, Vorinostat
Organ transplantation (NDC, HCPCS)
J7500, J7501 / Azathioprine
J7502, J7515, J7516 / Cyclosporine
J7507, J7525, 80197 / Tacrolimus anhydrous
M7517 / Mycophenolatemofetil
J7520 / Sirolimus
J7518 / Mycophenolate sodium
Tacrolimus, micronized
J7505 / Muromonab-CD3
J7513 / Daclizumab
J0480 / Basiliximab
J7599 / Immunosuppressive drug, not otherwise classified